Randomized Trial of Pre-Emptive or Prophylactic Valganciclovir Therapy for Prevention of Cytomegalovirus Infection in Renal Transplantation

被引：1
作者：
Delos Santos, Rowena [1 ]
Brennan, Daniel C. [1 ]
机构：
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2012年 / 23卷 / 09期
关键词：
ALLOGRAFT-REJECTION; ORAL GANCICLOVIR; GRAFT-SURVIVAL; CLINICAL-TRIAL; DISEASE; VALACYCLOVIR; RECIPIENTS; IMPACT;
D O I：
10.1681/ASN.2012070729
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1446 / 1448
页数：3
相关论文
共 13 条
[1]   METABOLIC-ACTIVATION OF THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-L-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE IN HUMAN-DIPLOID FIBROBLASTS INFECTED WITH HUMAN CYTOMEGALO-VIRUS [J].
BIRON, KK ;
STANAT, SC ;
SORRELL, JB ;
FYFE, JA ;
KELLER, PM ;
LAMBE, CU ;
NELSON, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (08) :2473-2477
[2]   Drug therapy - Ganciclovir [J].
Crumpacker, CS .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (10) :721-729
[3]   Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: Results of a randomized clinical trial [J].
Kliem, V. ;
Fricke, L. ;
Wollbrink, T. ;
Burg, M. ;
Radermacher, J. ;
Rohde, F. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (05) :975-983
[4]   Additional Evidence to Support Routine Cytomegalovirus Prophylaxis for All D+/R+ Renal Graft Recipients [J].
Kliem, Volker ;
Fricke, Lutz .
TRANSPLANTATION, 2012, 93 (06) :E21-E22
[5]   Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation [J].
Lowance, D ;
Neumayer, HH ;
Legendre, CM ;
Squifflet, JP ;
Kovarik, J ;
Brennan, PJ ;
Norman, D ;
Mendez, R ;
Keating, MR ;
Coggon, GL ;
Crisp, A ;
Lee, IC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (19) :1462-1470
[6]   LATE-ACUTE VENAL ALLOGRAFT-REJECTION AND SYMPTOMLESS CYTOMEGALOVIRUS-INFECTION [J].
REINKE, P ;
FIETZE, E ;
ODEHAKIM, S ;
PROSCH, S ;
LIPPERT, J ;
EWERT, R ;
VOLK, HD .
LANCET, 1994, 344 (8939-4) :1737-1738
[7]   Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation [J].
Reischig, T. ;
Jindra, P. ;
Hes, O. ;
Svecova, M. ;
Klaboch, J. ;
Treska, V. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (01) :69-77
[8]   Valacyclovir for cytomegalovirus prophylaxis reduces the risk of acute renal allograft rejection [J].
Reischig, T ;
Jindra, P ;
Mares, J ;
Cechura, M ;
Svecová, M ;
Hes, O ;
Opatrny, K ;
Treska, V .
TRANSPLANTATION, 2005, 79 (03) :317-324
[9]   Long-Term Outcomes of Pre-emptive Valganciclovir Compared with Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation [J].
Reischig, Tomas ;
Hribova, Petra ;
Jindra, Pavel ;
Hes, Ondrej ;
Bouda, Mirko ;
Treska, Vladislav ;
Viklicky, Ondrej .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (09) :1588-1597
[10]   Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival [J].
Sagedal, S ;
Hartmann, A ;
Nordal, KP ;
Osnes, K ;
Leivestad, T ;
Foss, A ;
Degré, M ;
Fauchald, P ;
Rollag, H .
KIDNEY INTERNATIONAL, 2004, 66 (01) :329-337
12